Leishmaniasis, Cutaneous - 18 Studies Found
| Available |
: Paromomycin for Individuals With Uncomplicated Cutaneous Leishmaniasis : Leishmaniasis, Cutaneous : 2012-06-18 : Drug: Paromomycin Paromomycin Topical Cream applied to all lesions once a day for 20 days |
| Completed |
: Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Cutaneous Leishmaniasis : Leishmaniasis, Cutaneous : 2005-05-23 : Biological: Leish-111f + MPL-SE vaccine |
| Terminated |
: Safety, Efficacy, and PK of Topical Paromomycin/Gentamicin Cream for Treatment of Cutaneous Leishmaniasis : Leishmaniasis, Cutaneous : 2010-06-07 : Drug: WR 279,396 Topical application of WR 279,396 cream (15% paromomycin + 0.5% gentamicin)once daily f |
| Completed |
: Safety, Efficacy and Pharmacokinetics (PK) Study of WR 279,396 Versus Paromomycin for Treatment of Cutaneous Leishmaniasis (Peru-PK) : Leishmaniasis, Cutaneous : 2009-12-14 :
|
| Completed |
: Pharmacokinetics, Safety, and Efficacy Trial of WR 279,396 (Paromomycin + Gentamicin Topical Cream) and Paromomycin Topical Cream for the Treatment of Cutaneous Leishmaniasis in Panama : Leishmaniasis, Cutaneous : 2010-03-08 :
|
| Completed |
: Topical 3% Amphotericin B Cream for the Treatment of Cutaneous Leishmaniasis in Colombia : Cutaneous Leishmaniasis : 2013-04-24 : Drug: Topical Amphotericin B at 3% Other Name: Anfoleish |
| Not yet recruiting |
: Miltefosine and GM-CSF in Cutaneous Leishmaniasis : Cutaneous Leishmaniasis : 2016-12-27 :
|
| Completed |
: Antimony Plus Pentoxifylline in Cutaneous Leishmaniasis : Cutaneous Leishmaniasis : 2011-06-23 :
|
| Completed |
: WR 279,396 for the Treatment of Cutaneous Leishmaniasis : Cutaneous Leishmaniasis : 2013-11-14 : Drug: WR 279,396 Paromomycin + Gentamicin Topical Cream |
| Completed |
: Efficacy and Safety of Pentamidine (7mg/kg) for Patients With Cutaneous Leishmaniasis Caused by L. Guyanensis : Cutaneous Leishmaniasis. : 2016-03-04 :
|